Information Provided By: 
Fly News Breaks for February 27, 2017
CYH, TFX, MASI
Feb 27, 2017 | 08:58 EDT
Wedbush analyst Tao Levy noted that flu activity remains elevated, which could have positive implications for Masimo's (MASI) pulse oximetry franchise in Q1. The analyst, who raised his price target on Masimo shares to $95 from $85, also noted that recent management comments from earnings calls held by Teleflex (TFX) and Community Health Systems (CYH) confirms his belief that healthcare utilization increased in Q1 from the same quarter of last year. He keeps an Outperform rating on Masimo shares.
News For MASI;TFX;CYH From the Last 2 Days
MASI
Apr 15, 2024 | 05:15 EDT
Stifel analyst Rick Wise upgraded Masimo to Buy from Hold with a price target of $170, up from $148. Multiple favorable developments strategically, commercially, and legally, including the recently announced Consumer separation, now have meaningfully changed Masimo's long-term outlook for the better, the analyst tells investors in a research note. The analyst thinks the stock has room for further share price appreciation given the company's imp[roved growth outlook and margin expansion.
